Medtronic plc subsidiary Covidien must face a broad bankruptcy court lawsuit accusing the medical device company of unfairly profiting billions from its 2013 spin-off of opioid manufacturer Mallinckrodt Plc.
A Chapter 11 trust set up for Mallinckrodt creditors has carried its burden to advance the bulk of a 2022 lawsuit against Covidien to recoup from alleged fraudulent transfers that left all of Covidien’s potential opioid liability with Mallinckrodt. Judge John T. Dorsey of the US Bankruptcy Court for the District of Delaware issued a 93-page ruling Thursday, dismissing some claims from the suit but allowing the trust to continue pursuing ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.